2-(2-Cyclohexyl-2-(tetrahydro-2H-pyran-4-yl)ethyl)piperidine

ID: ALA4097557

Chembl Id: CHEMBL4097557

PubChem CID: 137659684

Max Phase: Preclinical

Molecular Formula: C18H33NO

Molecular Weight: 279.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C1CCC(C(CC2CCCCN2)C2CCOCC2)CC1

Standard InChI:  InChI=1S/C18H33NO/c1-2-6-15(7-3-1)18(16-9-12-20-13-10-16)14-17-8-4-5-11-19-17/h15-19H,1-14H2

Standard InChI Key:  OHDUXXMFTDYBHG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4097557

    ---

Associated Targets(Human)

Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver (4264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cpt1b Carnitine palmitoyltransferase 1B (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 279.47Molecular Weight (Monoisotopic): 279.2562AlogP: 4.14#Rotatable Bonds: 4
Polar Surface Area: 21.26Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.58CX LogP: 3.84CX LogD: 0.93
Aromatic Rings: Heavy Atoms: 20QED Weighted: 0.83Np Likeness Score: 0.23

References

1. Tseng CC, Noordali H, Sani M, Madhani M, Grant DM, Frenneaux MP, Zanda M, Greig IR..  (2017)  Development of Fluorinated Analogues of Perhexiline with Improved Pharmacokinetic Properties and Retained Efficacy.,  60  (7): [PMID:28277663] [10.1021/acs.jmedchem.6b01592]

Source